Standard Uranium Ltd News - STND

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C...

Biofrontera reports preliminary revenue for the month of July 2021

Leverkusen, Germany, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock...

Biofrontera enters into license and supply agreement with Medac for the marketing of Ameluz® in Poland

Leverkusen, Germany, July 23, 2021 (GLOBE NEWSWIRE) -- Biofrontera Pharma GmbH, a wholly owned subsidiary of...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C...

Biofrontera Inc. seeks IPO in the USA

Leverkusen, Germany, July 06, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG currently holds 100 % of the shares of...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C...

Biofrontera reports preliminary revenue for the month of June 2021

Leverkusen, Germany, July 06, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C...

Biofrontera provides update on clinical developments

Leverkusen, Germany, June 22, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C...

Biofrontera reports preliminary revenue for the month of May 2021

Leverkusen, Germany, June 07, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock...

Biofrontera reports Q1 2021 financial results

Leverkusen, Germany, May 11, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange:...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C...

Biofrontera reports preliminary revenue for the month of April 2021

Leverkusen, Germany, May 06, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange:...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Standard Uranium Ltd (STND)

Professional-Grade Tools, for Individual Investors.

STND News

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Biofrontera reports preliminary revenue for the month of July 2021

Biofrontera enters into license and supply agreement with Medac for the marketing of Ameluz® in Poland

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Biofrontera Inc. seeks IPO in the USA

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Biofrontera reports preliminary revenue for the month of June 2021

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Biofrontera provides update on clinical developments

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Biofrontera reports preliminary revenue for the month of May 2021

Biofrontera reports Q1 2021 financial results

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Biofrontera reports preliminary revenue for the month of April 2021

STND Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Standard Uranium Ltd (STND) News

Standard Uranium Ltd (STND)

Professional-Grade Tools, for Individual Investors.

STND News

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Biofrontera reports preliminary revenue for the month of July 2021

Biofrontera enters into license and supply agreement with Medac for the marketing of Ameluz® in Poland

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Biofrontera Inc. seeks IPO in the USA

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Biofrontera reports preliminary revenue for the month of June 2021

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Biofrontera provides update on clinical developments

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Biofrontera reports preliminary revenue for the month of May 2021

Biofrontera reports Q1 2021 financial results

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Biofrontera reports preliminary revenue for the month of April 2021

STND Discussion

Your Recent History